{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:19:31Z","timestamp":1787505571606,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.tox.2020.152500","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T02:46:47Z","timestamp":1589597207000},"page":"152500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Altered expression of glutamatergic and GABAergic genes in the valproic acid-induced rat model of autism: A screening test"],"prefix":"10.1016","volume":"440","author":[{"given":"Jacek","family":"Lenart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Augustyniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy W.","family":"Lazarewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5817-5650","authenticated-orcid":false,"given":"Elzbieta","family":"Zieminska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2020.152500_bib0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tins.2007.12.005","article-title":"Neuroanatomy of autism","volume":"31","author":"Amaral","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tox.2020.152500_bib0010","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1007\/s12035-019-1538-x","article-title":"Reference gene validation via RT-qPCR for human iPSC-derived neural stem cells and neural progenitors","volume":"56","author":"Augustyniak","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tox.2020.152500_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fncel.2014.00058","article-title":"Genetic aspects of autism spectrum disorders: insights from animal models","volume":"8","author":"Banerjee","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tox.2020.152500_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-418700-9.00001-0","article-title":"Autism spectrum disorder and the cerebellum","volume":"113","author":"Becker","year":"2013","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.tox.2020.152500_bib0025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.crvi.2016.05.004","article-title":"Current knowledge on the genetics of autism and propositions for future research","volume":"339","author":"Bourgeron","year":"2016","journal-title":"C. R. Biol."},{"key":"10.1016\/j.tox.2020.152500_bib0030","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.tox.2020.152500_bib0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/B978-0-444-64189-2.00004-4","article-title":"Cerebellar involvement in autism and ADHD","volume":"155","author":"Bruchhage","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.tox.2020.152500_bib0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pnpbp.2018.11.017","article-title":"Metabotropic functions of the NMDA receptor and an evolving rationale for exploring NR2A-selective positive allosteric modulators for the treatment of autism spectrum disorder","volume":"90","author":"Burket","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.tox.2020.152500_bib0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.coph.2014.11.008","article-title":"NMDA receptor subunit mutations in neurodevelopmental disorders","volume":"20","author":"Burnashev","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.tox.2020.152500_bib0050","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00702-008-0142-4","article-title":"A population-based association study of glutamate decarboxylase 1 as a candidate gene for autism","volume":"116","author":"Buttenschon","year":"2009","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.tox.2020.152500_bib0055","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.pbb.2011.02.003","article-title":"Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders","volume":"100","author":"Carlson","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tox.2020.152500_bib0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fped.2014.00070","article-title":"GABAergic signaling as therapeutic target for autism spectrum disorders","volume":"2","author":"Cellot","year":"2014","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.tox.2020.152500_bib0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1469-8749.1994.tb11858.x","article-title":"Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs","volume":"36","author":"Christianson","year":"1994","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.tox.2020.152500_bib0070","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.978","article-title":"Autism throughout genetics: perusal of the implication of ion channels","volume":"8","author":"Daghsni","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.tox.2020.152500_bib0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.brainres.2016.07.011","article-title":"Measuring neural excitation and inhibition in autism: different approaches, different findings and different interpretations","volume":"1648","author":"Dickinson","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.tox.2020.152500_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00343800","article-title":"Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders","volume":"229","author":"Emrich","year":"1980","journal-title":"Arch. Psychiatr. Nervenkr."},{"key":"10.1016\/j.tox.2020.152500_bib0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12311-008-0075-3","article-title":"Expression of GABA(B) receptors is altered in brains of subjects with autism","volume":"8","author":"Fatemi","year":"2009","journal-title":"Cerebellum"},{"key":"10.1016\/j.tox.2020.152500_bib0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10803-008-0646-7","article-title":"GABA(A) receptor downregulation in brains of subjects with autism","volume":"39","author":"Fatemi","year":"2009","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.tox.2020.152500_bib0095","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10803-009-0924-z","article-title":"mRNA and protein levels for GABAAalpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism","volume":"40","author":"Fatemi","year":"2010","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.tox.2020.152500_bib0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11920-018-0874-2","article-title":"Sex differences in autism Spectrum disorder: a review","volume":"20","author":"Ferri","year":"2018","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.tox.2020.152500_bib0105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fnmol.2018.00387","article-title":"Metabotropic glutamate receptor 7: a new therapeutic target in neurodevelopmental disorders","volume":"11","author":"Fisher","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tox.2020.152500_bib0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coph.2005.11.005","article-title":"Glutamate- and GABA-based CNS therapeutics","volume":"6","author":"Foster","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.tox.2020.152500_bib0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neures.2009.05.002","article-title":"Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions","volume":"65","author":"Fukuchi","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.tox.2020.152500_bib0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/1566524015666150303003028","article-title":"Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders","volume":"15","author":"Gao","year":"2015","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.tox.2020.152500_bib0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00213-006-0317-3","article-title":"Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex","volume":"185","author":"Gobbi","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tox.2020.152500_bib0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41398-018-0155-1","article-title":"Glutamate and GABA in autism spectrum disorder-a translational magnetic resonance spectroscopy study in man and rodent models","volume":"8","author":"Horder","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tox.2020.152500_bib0135","first-page":"166","article-title":"Memantine: a review of possible uses in child and adolescent psychiatry","volume":"22","author":"Hosenbocus","year":"2013","journal-title":"J. Can. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.tox.2020.152500_bib0140","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fnbeh.2018.00182","article-title":"A developmental study of abnormal behaviors and altered GABAergic signaling in the VPA-Treated rat model of autism","volume":"12","author":"Hou","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.tox.2020.152500_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023751","article-title":"Brain region-specific decrease in the activity and expression of protein kinase A in the frontal cortex of regressive autism","volume":"6","author":"Ji","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2020.152500_bib0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: past, present, and future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.tox.2020.152500_bib0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fnmol.2015.00017","article-title":"Suppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors","volume":"8","author":"Kang","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tox.2020.152500_bib0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S1461145711001714","article-title":"Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid","volume":"16","author":"Kataoka","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.tox.2020.152500_bib0165","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/jnc.12147","article-title":"Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder","volume":"124","author":"Kim","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tox.2020.152500_bib0170","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5607\/en.2017.26.5.252","article-title":"Valproic acid induces telomerase reverse transcriptase expression during cortical development","volume":"26","author":"Kim","year":"2017","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.tox.2020.152500_bib0175","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41386-018-0098-5","article-title":"Pharmacological modulation of AMPA receptor rescues social impairments in animal models of autism","volume":"44","author":"Kim","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tox.2020.152500_bib0180","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.3390\/ijms16023095","article-title":"Neuron membrane trafficking and protein kinases involved in autism and ADHD","volume":"16","author":"Kitagishi","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tox.2020.152500_bib0185","doi-asserted-by":"crossref","first-page":"a258","DOI":"10.1289\/ehp.1104285","article-title":"A research strategy to discover the environmental causes of autism and neurodevelopmental disabilities","volume":"120","author":"Landrigan","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2020.152500_bib0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coph.2014.10.007","article-title":"NMDA receptor dysfunction in autism spectrum disorders","volume":"20","author":"Lee","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.tox.2020.152500_bib0195","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.biopsych.2016.05.011","article-title":"Excitation\/inhibition imbalance in animal models of autism spectrum disorders","volume":"81","author":"Lee","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tox.2020.152500_bib0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gep.2017.06.006","article-title":"Lateralization of housekeeping genes in the brain of one-day old chicks","volume":"25\u201326","author":"Lenart","year":"2017","journal-title":"Gene Expr. Patterns"},{"key":"10.1016\/j.tox.2020.152500_bib0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2017.06.018","article-title":"Reduced protein expressions of cytomembrane GABAARbeta3 at different postnatal developmental stages of rats exposed prenatally to valproic acid","volume":"1671","author":"Li","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.tox.2020.152500_bib0210","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ajmg.b.32306","article-title":"Rare de novo deletion of metabotropic glutamate receptor 7 (GRM7) gene in a patient with autism spectrum disorder","volume":"168B","author":"Liu","year":"2015","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.tox.2020.152500_bib0215","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(18)31129-2","article-title":"Autism spectrum disorder","volume":"392","author":"Lord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2020.152500_bib0220","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"Loscher","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.tox.2020.152500_bib0225","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"Loscher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.tox.2020.152500_bib0230","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.2147\/NDT.S165375","article-title":"Frontal lobe metabolic alterations in autism spectrum disorder: a (1)H-magnetic resonance spectroscopy study","volume":"14","author":"Margari","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.tox.2020.152500_bib0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fncel.2014.00023","article-title":"Late onset deficits in synaptic plasticity in the valproic acid rat model of autism","volume":"8","author":"Martin","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tox.2020.152500_bib0240","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tox.2020.152500_bib0245","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbr.2013.09.049","article-title":"Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice","volume":"257","author":"Moldrich","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.tox.2020.152500_bib0250","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S1355617710001359","article-title":"The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy","volume":"17","author":"Nadebaum","year":"2011","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.tox.2020.152500_bib0255","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0773.1991.tb01303.x","article-title":"Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms","volume":"69","author":"Nau","year":"1991","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.tox.2020.152500_bib0260","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tox.2020.152500_bib0265","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/aur.1640","article-title":"Glutamate receptor, metabotropic 7 (GRM7) gene variations and susceptibility to autism: a case-control study","volume":"9","author":"Noroozi","year":"2016","journal-title":"Autism Res."},{"key":"10.1016\/j.tox.2020.152500_bib0270","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1126\/science.1227764","article-title":"Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders","volume":"338","author":"O\u2019Roak","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.tox.2020.152500_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.tox.2020.152500_bib0280","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2174\/1570159X13666150716165323","article-title":"Metabotropic glutamate receptor 7: from synaptic function to therapeutic implications","volume":"14","author":"Palazzo","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.tox.2020.152500_bib0285","doi-asserted-by":"crossref","first-page":"8296","DOI":"10.1038\/srep08296","article-title":"Association of genetic variants of GRIN2B with autism","volume":"5","author":"Pan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2020.152500_bib0290","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tins.2006.05.010","article-title":"Searching for ways out of the autism maze: genetic, epigenetic and environmental clues","volume":"29","author":"Persico","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tox.2020.152500_bib0295","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2020.152500_bib0300","series-title":"GeneReviews((R))","article-title":"GRIN2B-related neurodevelopmental disorder","author":"Platzer","year":"1993"},{"key":"10.1016\/j.tox.2020.152500_bib0305","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated autistic disorder","volume":"47","author":"Rasalam","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.tox.2020.152500_bib0310","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/FBP.0000000000000169","article-title":"Effects of prenatal exposure to valproic acid on the development of juvenile-typical social play in rats","volume":"26","author":"Raza","year":"2015","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.tox.2020.152500_bib0315","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.0704391104","article-title":"Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid","volume":"104","author":"Rinaldi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tox.2020.152500_bib0320","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00702-014-1216-0","article-title":"The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment","volume":"121","author":"Rojas","year":"2014","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.tox.2020.152500_bib0325","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neuroscience.2010.06.069","article-title":"Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid","volume":"170","author":"Roullet","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.tox.2020.152500_bib0330","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism--a current review of clinical and animal studies","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.tox.2020.152500_bib0335","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tox.2020.152500_bib0340","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","article-title":"Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid","volume":"33","author":"Schneider","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.tox.2020.152500_bib0345","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1212\/WNL.0b013e3182088297","article-title":"Child development following in utero exposure: levetiracetam vs sodium valproate","volume":"76","author":"Shallcross","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.tox.2020.152500_bib0350","article-title":"Ultrasonic vocalizations as a tool in studying emotional states in rodent models of social behavior and brain disease","author":"Simola","year":"2018","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.tox.2020.152500_bib0355","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-61779-111-6_2","article-title":"Dissection of rodent brain regions","volume":"57","author":"Spijker","year":"2011","journal-title":"Neuromethods"},{"key":"10.1016\/j.tox.2020.152500_bib0360","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3389\/fgene.2019.00707","article-title":"Target genes of autism risk loci in brain frontal cortex","volume":"10","author":"Sun","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.tox.2020.152500_bib0365","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1038\/tp.2011.52","article-title":"Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia","volume":"1","author":"Tarabeux","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tox.2020.152500_bib0370","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/WNF.0000000000000033","article-title":"A trial of D-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorder","volume":"37","author":"Urbano","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.tox.2020.152500_bib0375","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00401-017-1736-4","article-title":"Autism spectrum disorder: neuropathology and animal models","volume":"134","author":"Varghese","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tox.2020.152500_bib0380","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2018.09.042","article-title":"GABArho3 expression in lobule X of the cerebellum is reduced in the valproate model of autism","volume":"687","author":"Varman","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tox.2020.152500_bib0385","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3389\/fphar.2018.01185","article-title":"Potentiation of glutamatergic synaptic transmission onto dorsal raphe serotonergic neurons in the valproic acid model of autism","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tox.2020.152500_bib0390","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.lfs.2012.11.010","article-title":"Role of metabotropic glutamate receptor 7 in autism spectrum disorders: a pilot study","volume":"92","author":"Yang","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.tox.2020.152500_bib0395","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1038\/s41598-017-03666-0","article-title":"GABAA receptor subunit gene polymorphisms predict symptom-based and developmental deficits in Chinese Han children and adolescents with autistic spectrum disorders","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2020.152500_bib0400","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2012.01.061","article-title":"Family based association of GRIN2A and GRIN2B with Korean autism spectrum disorders","volume":"512","author":"Yoo","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tox.2020.152500_bib0405","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fnmol.2018.00418","article-title":"Glutamate, glutamine and GABA levels in rat brain measured using MRS, HPLC and NMR methods in study of two models of autism","volume":"11","author":"Zieminska","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tox.2020.152500_bib0410","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF00632534","article-title":"Ultraschall-Laute bei jungen M\u00e4usen","volume":"43","author":"Zippelius","year":"1956","journal-title":"Naturwissenschaften"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X20301396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X20301396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:44:19Z","timestamp":1759535059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X20301396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":82,"alternative-id":["S0300483X20301396"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2020.152500","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered expression of glutamatergic and GABAergic genes in the valproic acid-induced rat model of autism: A screening test","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2020.152500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152500"}}